Th17 immune microenvironment in Epstein-Barr virus–negative Hodgkin lymphoma: implications for immunotherapy

Classical Hodgkin lymphoma (CHL) is a neoplasm characterized by robust inflammatory infiltrates and heightened expression of the immunosuppressive PD-1/PD-L1 pathway. Although anti-PD-1 therapy can be effective in >60% of patients with refractory CHL, improved treatment options are needed for CHL...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Duffield, Amy S., Ascierto, Maria Libera, Anders, Robert A., Taube, Janis M., Meeker, Alan K., Chen, Shuming, McMiller, Tracee L., Phillips, Neil A., Xu, Haiying, Ogurtsova, Aleksandra, Berger, Alan E., Pardoll, Drew M., Topalian, Suzanne L., Ambinder, Richard F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2017
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727974/
https://ncbi.nlm.nih.gov/pubmed/29296775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017007260
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller